MOLBIO vs MPIMANIPAL: Stock Comparison

Head-to-head financial and trading comparison between Molbio Diagnostics Limited (MOLBIO) and Manipal Payment and Identity Solutions Limited (MPIMANIPAL) in the Cross-Sector Peers sector.

MOLBIO

NSE: MOLBIO
Molbio Diagnostics Limited
₹1,438.60
1Y Return: +38.1%
52W High: ₹1,544.70
52W Low: ₹1,036.65
Annual Volatility: 95.93%
Check MOLBIO Trade Fees →

MPIMANIPAL

NSE: MPIMANIPAL
Manipal Payment and Identity Solutions Limited
₹362.00
1Y Return: +4.88%
52W High: ₹417.40
52W Low: ₹336.60
Annual Volatility: 72.13%
Check MPIMANIPAL Trade Fees →

Key Metrics Comparison Table

MetricMOLBIOMPIMANIPALEdge / Winner
Current Market Price (CMP) ₹1,438.60 ₹362.00 —
1-Year Price Return +38.1% +4.88% MOLBIO (33.22% higher)
52-Week High ₹1,544.70 ₹417.40 —
52-Week Low ₹1,036.65 ₹336.60 —
30-Day Annualized Volatility 95.93% 72.13% MPIMANIPAL (Steadier)
30-Day Average Daily Volume 3,210,458 3,151,694 MOLBIO (Higher Liquidity)
Statutory Cost to Trade ₹1 Lakh ₹118.50 ₹118.50 Identical statutory tariff

Frequently Asked Questions

Between MOLBIO and MPIMANIPAL, which stock gave better returns over the last year?

MOLBIO has outperformed MPIMANIPAL over the past 12 months with a gain of 38.1% compared to 4.88%.

Which stock is less volatile: MOLBIO or MPIMANIPAL?

MPIMANIPAL demonstrated lower price volatility (72.13% annualized) compared to MOLBIO (95.93%). Lower volatility generally indicates steadier price action during market downturns.

What is the statutory cost to buy ₹1,00,000 of MOLBIO vs MPIMANIPAL?

Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).

Are MOLBIO and MPIMANIPAL direct sector competitors?

Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.